Along with diet, exercise, and support from a medical provider, the drug can help patients lose weight and learn to live a healthier lifestyle without the worry of major setbacks
Zepbound now carries an obstructive sleep apnea indication as well as its weight indications, and Foundayo (orforglipron), approved April 1 2026, is an oral product indicated for chronic weight management
Questions to Discuss With Your Provider When considering compounded generic medical weight loss medications, ask about: How the formulation is tailored to your medical history
Also, it will have an impact on the broader ecosystem of healthcare services, potentially changing your patients population characteristics and their journey
(2) Dose adjustment: Start elderly patients on a low dose and gradually adjust according to their tolerance and response, avoiding high doses
Some patients experience significant appetite reduction, whilst others notice more modest effects